RGDXQ (Response Genetics) Net Margin %: 0.00% (As of Dec. 2015)


What is Response Genetics Net Margin %?

Response Genetics RGDXQ -98.00% Net Margin % is 0.00% as of Dec. 2015.

Net margin is calculated as Net Income divided by its Revenue. Response Genetics's Net Income for the three months ended in Dec. 2015 was $0.00 Mil. Response Genetics's Revenue for the three months ended in Dec. 2015 was $0.00 Mil. Therefore, Response Genetics's net margin for the quarter that ended in Dec. 2015 was 0.00%.

The historical rank and industry rank for Response Genetics's Net Margin % or its related term are showing as below:


RGDXQ's Net Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -2.69
* Ranked among companies with meaningful Net Margin % only.

Response Genetics  (OTCPK:RGDXQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Response Genetics Net Margin % Related Terms

Response Genetics Net Margin % Historical Data

* Premium members only.

The historical data trend for Response Genetics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Genetics Net Margin % Chart

Response Genetics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.18 -41.40 -187.19 -163.18 -111.88

Response Genetics Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Dec15
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.32 -81.61 260.28 -105.99 0.00

RGDXQ vs PSID, GBSN, ETAH: Net Margin % Comparison

For the Diagnostics & Research subindustry, Response Genetics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Genetics Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Response Genetics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Response Genetics's Net Margin % falls into.


Response Genetics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Response Genetics's Net Margin for the fiscal year that ended in Dec. 2015 is calculated as

Net Margin=Net Income (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=-20.184/18.04
=-111.88 %

Response Genetics's Net Margin for the quarter that ended in Dec. 2015 is calculated as

Net Margin=Net Income (Q: Dec. 2015 )/Revenue (Q: Dec. 2015 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Response Genetics (RGDXQ) has a Net Margin % of 0.00% as of Dec. 2015. Net margin is the ratio of total net income to net sales. View historical data on Response Genetics and its competitors.
Is Response Genetics' Net Margin % too high?
Response Genetics' current Net Margin % is 0.00%.
How does Response Genetics' Net Margin % compare to PSID and GBSN?
Response Genetics' Net Margin % of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Response Genetics and its competitors. Response Genetics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Net Margin % is 0.00% as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Response Genetics Business Description

Address 201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.